Abstract
HDAC as a cancer target: various scaffold. Based HDAC inhibitors and overview of their advances
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have